Form 4: VolitionRx Ltd. Executive Receives Stock Award in Lieu of Cash Compensation

Jasmine Kway, CEO Singapore Volition, received 15,668 restricted stock units (RSUs) from VolitionRx Ltd. in lieu of cash compensation on September 1, 2024.

Summary

• On September 1, 2024, Jasmine Kway, CEO Singapore Volition, received 15,668 restricted stock units (RSUs) from VolitionRx Ltd.
• The RSUs were awarded under the Issuer's 2015 Stock Incentive Plan as a substitute for cash compensation.
• The RSUs vest in three installments: 5,223 units on September 1, 2024, 5,223 units on October 1, 2024, and 5,222 units on November 1, 2024.
• The RSUs are also subject to further time-based vesting in a single installment on June 1, 2025, contingent upon continued service.
• Upon vesting and settlement, Kway will receive common stock shares equal to the number of vested RSUs.
• Following the transaction, Kway directly owns 150,903 shares of common stock and indirectly owns 10,400 shares through a spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock awards to an executive, which is neither particularly positive nor negative.

Positives

• The award of RSUs aligns the executive's interests with those of the shareholders.
• Using RSUs instead of cash may preserve the company's cash reserves.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The RSU award may have a slightly dilutive effect on existing shareholders.
• The award incentivizes the executive to perform well, potentially benefiting shareholders.

Key Dates